N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-2-(pyridin-2-ylmethoxy)-isonicotinamide | 535923-62-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并噻唑类
• 英文名称: N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-2-(pyridin-2-ylmethoxy)-isonicotinamide
• 英文别名: N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-2-(pyridin-2-ylmethoxy)pyridine-4-carboxamide
• CAS: 535923-62-7
• 化学式: C₂₄H₂₃N₅O₄S
• 分子量: 477.544
• InChiKey: GQZKXXKRDZFSIY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  34
• 可旋转键数：
  7
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  127
• 氢给体数：
  1
• 氢受体数：
  9

反应信息

• 作为产物：
  描述：

  2-吡啶甲醇 、 2-氯-N-(4-甲氧基-7-吗啉-4-基-苯并噻唑-2-基)-异烟酰胺 以 1,4-二氧六环 为溶剂， 生成 N-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-2-(pyridin-2-ylmethoxy)-isonicotinamide
  参考文献：
  名称：

  Isonicotin- and nicotinamide derivatives of benzothiazoles

  摘要：

  本发明涉及具有以下公式的化合物1，其中R1、A和R如内部所述。本发明的化合物已被发现是腺苷受体配体。特别是，本发明的化合物对A2A受体具有亲和力，因此在治疗与该受体相关的疾病中非常有用。

  公开号：

  US20030134854A1

文献信息

• LUBRICATING OIL ADDITIVE CONTAINING ACRYLIC POLYMER AND LUBRICATING OIL COMPOSITIONS
  申请人：KURARAY CO., LTD.

  公开号：EP1795581A1

  公开（公告）日：2007-06-13

  A lubricating oil additive containing at least one acrylic block copolymer having a weight-average molecular weight of 10,000 to 1,000,000 and a molecular weight distribution [ratio of weight-average molecular weight (Mw) to number-average molecular weight (Mn), i.e. Mw/Mn ratio] of 1.5 or below and lubricating oil compositions containing the additive. The lubricating oil additive exhibits a thickening effect higher than those of conventional acrylic lubricating oil additives and can improve the viscosity index of lubricating oil even when added in a small amount. Further, the additive can also improve the low-temperature characteristics, flow characteristics, and shear stability. The lubricating oil compositions enable energy saving and can lengthen the lifetime of lubricating oil and reduce the load on the global environment.

  一种润滑油添加剂，至少含有一种重量平均分子量为 10,000 至 1,000,000 且分子量分布[重量平均分子量（Mw）与数均分子量（Mn）之比，即 Mw/Mn 比]为 1.5 或以下的丙烯酸嵌段共聚物，以及含有该添加剂的润滑油组合物。该润滑油添加剂的增稠效果高于传统的丙烯酸润滑油添加剂，即使添加量很小，也能提高润滑油的粘度指数。此外，添加剂还能改善低温特性、流动特性和剪切稳定性。这种润滑油组合物可以节约能源，延长润滑油的使用寿命，减轻对全球环境的负荷。
• NICOTIN-OR ISONICOTIN BENZOTHIAZOLE DERIVATIVES
  申请人：F. HOFFMANN-LA ROCHE AG

  公开号：EP1448198A1

  公开（公告）日：2004-08-25
• LUBRICATING OIL COMPOSITION CONTAINING ACRYLIC POLYMER
  申请人：KURARAY CO., LTD.

  公开号：EP1795581B1

  公开（公告）日：2018-09-19
• US6620811B2
  申请人：——

  公开号：US6620811B2

  公开（公告）日：2003-09-16
• [EN] NICOTIN-OR ISONICOTIN BENZOTHIAZOLE DERIVATIVES<br/>[FR] DERIVES DE NICOTINE OU D'ISONICOTINE BENZOTHIAZOLE
  申请人：HOFFMANN LA ROCHE

  公开号：WO2003043636A1

  公开（公告）日：2003-05-30

  The present invention relates to compounds of the general formula(I) wherein R1 is phenyl, piperidin-1-yl or morpholinyl; A is-O-and R is-(CH¿2?)n-N(R')-C(O)-lower alkyl, -(CH2)n-O-lower alkyl, -(CH2)n-O-(CH2)n-O-lower alkyl, lower alkyl, -(CH2)n-morpholinyl, -(CH2)n-phenyl,-(CH2)n-N(R')2, (CH2)n-pyridinyl, -(CH2)n-CF3, (CH2)n-2-oxo-pyrrolidinyl or C4-6-cycloalkyl; R' is independently from each other hydrogen or lower alkyl and n is 1 or 2; or A is-N(R')-and R is lower alkyl, C4-6-cycloalkyl, -(CH2)n-O-lower alkyl, -(CH2)n-pyridinyl, -(CH2)n-piperidinyl, -(CH2)n-phenyl, (CH2)n-N(R')-C(O)-lower alkyl, -(CH2)n-morpholinyl, or (CH2)n-N(R')2; R' and R' are independently from each other hydrogen or lower alkyl and n is 1 or 2; or A is CH2- and R is-N(R')-(CH2)m-O-lower alkyl, -N(R')2 S-lower alkyl, or is acetidinyl, pyrrolidinyl or piperidinyl, which optionally substituted by hydroxy or lower alkoxy or is morpholinyl, -N(R')-CH2)m-C4-6-cycloalkyl, -N(R')-(CH2m-C(O)O-lower alkyl, -N(R')-(CH2)m-C(O)OH, -2-oxo pyrrolidinyl, -N(R')-C(O)O-lower alkyl, -O(CH2)m-O-lower alkyl or alkoxy; R' is independently from each other hydrogen or lower alkyl and m is 1, 2 or 3; A is S- and R is lower alkyl; or A-R are together piperazinyl, substituted by lower alkyl, -C(O)-lower alkyl or a oxo group, or is piperidinyl, substituted by lower alkoxy or hydroxy, or is morpholinyl, substituted by lower alkyl, or is C4-6-cycloalkyl, -azetidin-1-yl, optionally substituted by hydroxy or lower alkoxy, thiomorpholine-1,1-dioxo, -tetrahydopyran or 2-oxa-5-aza-bicyclo[2.2.1]hept-5-yl; and to pharmaceutically acceptable acid addition salts thereof. It has been found that the compounds of general formula I are adenosine receptor ligands. Specifically, the compounds of the present invention have a good affinity to the A2A-receptor and they are therefore useful in the treatment of diseases related to this receptor.